February 5, 2026

MedPage Today highlighted research led by the University of Cincinnati's Joseph Broderick that found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding following a type of stroke called an intracerebral hemorrhage (ICH).

February 4, 2026

The University of Cincinnati’s Joseph Broderick, MD, presented results from the FASTEST trial at the International Stroke Conference, simultaneously published in The Lancet, that found administering a synthetic protein, recombinant Factor VIIa, can reduce bleeding and potentially improve outcomes for certain patients at the highest risk of continued bleeding following an intracerebral hemorrhage.

February 3, 2026

A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.

January 30, 2026

The University of Cincinnati's Joseph Broderick, MD, was featured in a U.S. News & World Report article commenting on new research being presented at the International Stroke Conference that found stroke survivors might benefit from electromagnetic pulses that stimulate their brains and spur on their recovery.

January 29, 2026

University of Cincinnati researchers are presenting research at the International Stroke Conference 2026 in New Orleans Feb. 4-6.

January 27, 2026

The University of Cincinnati Cancer Center's Ian Paquette and patient Patty Goering were featured in a Jacksonville television station News4Jax report on nonsurgical options to treat colorectal cancer.

January 26, 2026

The University of Cincinnati's Rani Nasser, MD, was featured in a Fox 19 report discussing ways to stay safe when shoveling snow after winter storms.

January 23, 2026

The Dayton Daily News highlighted the journey of University of Cincinnati James L. Winkle College of Pharmacy alumnus Doug Wurtzbacher, who now runs STEM after school programs and camps for students through his business iCode.

January 23, 2026

The University of Cincinnati Cancer Center’s Tom Cunningham has received a two-year, $150,000 grant from the Lung Cancer Research Foundation (LCRF) to test approaches to neutralize an enzyme complex that plays a vital role in the growth of KRAS-mutated lung cancers.

January 22, 2026

The University of Cincinnati is a site for a clinical trial testing a new approach to manage severe headaches that occur following subarachnoid hemorrhage (SAH), a type of stroke that accounts for approximately 10% of all strokes and affects 30,000 Americans each year.